I now have all the material needed. Let me compile the complete, exam-ready long answer.
Mechanism of Secretion of Insulin, Functions of Insulin, and Diabetes Mellitus
INTRODUCTION
Insulin is a polypeptide hormone secreted by the beta (β) cells of the Islets of Langerhans in the pancreas. It is the principal anabolic and glucoregulatory hormone of the body, responsible for maintaining blood glucose within the normal range of 70-140 mg/dL.
PART 1: MECHANISM OF SECRETION OF INSULIN
A. Synthesis of Insulin
Insulin is synthesized through a sequential process in the β cells:
- Preproinsulin - synthesized on ribosomes of the rough endoplasmic reticulum (RER); contains a signal peptide
- Proinsulin - signal peptide is cleaved in the RER; proinsulin is transported to the Golgi apparatus
- Insulin + C-peptide - proinsulin is packaged into secretory granules in the Golgi, where enzymatic cleavage removes the connecting (C) peptide, yielding the active two-chain insulin molecule (A-chain + B-chain linked by 2 disulfide bonds) and equimolar quantities of C-peptide
- The secretory granules are stored in the β cell cytoplasm until release is triggered
Clinical Note: C-peptide has a longer plasma half-life than insulin and is not metabolized by the liver. It is therefore a reliable biomarker for measuring endogenous insulin secretion.
Insulin has a very short plasma half-life of ~6 minutes and is degraded primarily by insulin-degrading enzyme in the liver and kidneys.
B. Stimuli for Insulin Secretion
| Stimuli | Examples |
|---|
| Primary stimulus | Elevated blood glucose (most important) |
| Amino acids | Arginine, leucine (after a protein-rich meal) |
| Gastrointestinal hormones | GIP (glucose-dependent insulinotropic peptide), GLP-1, CCK, secretin |
| Autonomic nervous system | Vagal (parasympathetic) stimulation via ACh on muscarinic receptors |
| Drugs | Sulfonylureas (close K⁺ channels directly) |
| Other hormones | Glucagon, cortisol, growth hormone (pharmacological doses) |
Inhibitors of insulin secretion: somatostatin, sympathetic stimulation (α₂ adrenergic), hypoglycemia, diazoxide
C. Step-by-Step Mechanism of Glucose-Stimulated Insulin Secretion
This is the most important mechanism and follows the K⁺-ATP channel model:
Figure: Nutrient regulation of insulin secretion - Goldman-Cecil Medicine
Steps:
Step 1 - Glucose uptake:
- Rising blood glucose after a meal is taken up by β cells via GLUT-2 transporter (high Km, insulin-independent, acts as a glucose sensor)
Step 2 - Phosphorylation by glucokinase:
- Glucose is phosphorylated to glucose-6-phosphate by glucokinase (hexokinase IV), which acts as the "glucose sensor" of the β cell
- Glucokinase is not inhibited by its product (no product inhibition), so phosphorylation is proportional to glucose concentration
Step 3 - Increased ATP/ADP ratio:
- Glucose-6-phosphate enters glycolysis and the Krebs cycle
- This leads to a rise in intracellular ATP and an increase in the ATP/ADP ratio
Step 4 - Closure of K⁺-ATP channels:
- The elevated ATP closes the ATP-sensitive potassium channels (K⁺-ATP channels / K-ATP channels)
- The K⁺-ATP channel is composed of SUR1 (sulfonylurea receptor 1) and Kir6.2 (inward rectifier K⁺ channel subunit)
- In the fasting state, these channels are open, allowing K⁺ efflux and keeping the membrane hyperpolarized
Step 5 - Membrane depolarization:
- Closure of K⁺-ATP channels prevents K⁺ efflux
- This leads to membrane depolarization of the β cell
Step 6 - Opening of voltage-gated Ca²⁺ channels:
- Depolarization opens voltage-gated L-type calcium channels
- Ca²⁺ flows into the β cell from the extracellular space
Step 7 - Calcium-mediated exocytosis:
- The increased intracellular Ca²⁺ binds to calmodulin, which activates myosin light-chain kinase
- This causes mobilization of insulin secretory granules toward the cell membrane
- Granules fuse with the plasma membrane → exocytosis of insulin (and equimolar C-peptide + small amount of proinsulin) into the portal circulation
Glucose → GLUT-2 → Glucokinase → Glucose-6-P
→ ↑ATP/ADP ratio → K-ATP channel closes
→ Membrane depolarization → Ca²⁺ channel opens
→ ↑Intracellular Ca²⁺ → Exocytosis of insulin granules
D. Biphasic Pattern of Insulin Secretion
After a glucose stimulus, insulin is released in two phases:
- First phase (rapid, 0-10 min): Release of pre-formed insulin granules already docked at the membrane
- Second phase (sustained, 10-60 min): Newly synthesized insulin granules are mobilized and released; requires ongoing glucose metabolism
In Type 2 DM, the first-phase insulin response is characteristically lost, which is an early defect in β cell function.
PART 2: FUNCTIONS OF INSULIN
Insulin is an anabolic hormone with widespread metabolic effects. Its receptor is a receptor tyrosine kinase (tetramer: 2α + 2β subunits). Insulin binding to α subunits activates the β subunit tyrosine kinase → autophosphorylation → phosphorylation of Insulin Receptor Substrates (IRS) → multiple downstream signaling cascades.
A. Effects on Carbohydrate Metabolism (ANTI-HYPERGLYCEMIC)
| Action | Mechanism |
|---|
| ↑ Glucose uptake into muscle and adipose | Recruits GLUT-4 transporters to cell surface |
| ↑ Glycolysis | Activates phosphofructokinase (PFK-1) |
| ↑ Glycogen synthesis | Activates glycogen synthase |
| ↓ Glycogenolysis | Inhibits glycogen phosphorylase |
| ↓ Gluconeogenesis | Inhibits PEPCK and glucose-6-phosphatase in liver |
Brain, RBCs, renal tubules, intestinal mucosa do NOT require insulin for glucose uptake (use GLUT-1, GLUT-3).
B. Effects on Fat (Lipid) Metabolism (ANTI-LIPOLYTIC)
| Action | Effect |
|---|
| ↑ Lipogenesis | Activates acetyl-CoA carboxylase and fatty acid synthase; promotes triglyceride synthesis |
| ↓ Lipolysis | Inhibits hormone-sensitive lipase in adipocytes |
| ↓ Ketogenesis | By reducing free fatty acid availability for the liver |
| ↑ Lipoprotein lipase activity | Promotes triglyceride uptake from blood into fat cells |
C. Effects on Protein Metabolism (ANABOLIC)
| Action | Effect |
|---|
| ↑ Amino acid uptake | Into muscle and other cells |
| ↑ Protein synthesis | Stimulates ribosomal activity and gene transcription |
| ↓ Protein catabolism | Inhibits proteolysis and reduces urinary nitrogen loss |
D. Effects on Potassium Balance
- Insulin activates Na⁺-K⁺-ATPase, promoting K⁺ uptake into cells
- After a meal, insulin ensures that absorbed dietary K⁺ is taken into cells → prevents hyperkalemia
- Insulin deficiency → decreased cellular K⁺ uptake → hyperkalemia
E. Growth and Mitogenic Effects
- Promotes DNA synthesis and cell proliferation
- Stimulates growth and differentiation of many cell types
- Works synergistically with IGF-1 (Insulin-like Growth Factor-1)
F. Summary Table of Insulin Actions
| Tissue | Major Actions |
|---|
| Liver | ↑ Glycogen synthesis, ↑ lipogenesis, ↓ glycogenolysis, ↓ gluconeogenesis, ↓ ketogenesis |
| Skeletal Muscle | ↑ Glucose uptake (GLUT-4), ↑ glycogen synthesis, ↑ protein synthesis |
| Adipose Tissue | ↑ Glucose uptake, ↑ lipogenesis, ↓ lipolysis |
| General | ↑ K⁺ uptake into cells, cell growth and division |
PART 3: NOTE ON DIABETES MELLITUS
Definition
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia (elevated blood glucose) resulting from defects in insulin secretion, insulin action, or both.
Classification of Diabetes Mellitus
(American Diabetes Association classification)
| Type | Key Feature |
|---|
| Type 1 DM | Autoimmune destruction of β cells → absolute insulin deficiency |
| Type 2 DM | Combination of insulin resistance + relative insulin deficiency |
| Gestational DM | Glucose intolerance first detected during pregnancy |
| Other specific types | MODY (monogenic), pancreatic disease, endocrinopathies, drugs |
Type 1 Diabetes Mellitus
- Accounts for 5-10% of all diabetes cases
- Most common in children and young adults (peak onset 10-14 years)
- Pathogenesis: Autoimmune "insulitis" - T-cell mediated destruction of β cells → autoantibodies (anti-GAD, anti-islet cell antibodies, anti-insulin antibodies) can be detected
- Genetic link to HLA class II genes (HLA-DR3, HLA-DR4)
- Absolute insulin deficiency
- Without insulin treatment: Diabetic ketoacidosis (DKA) develops
Features: Polyuria, polydipsia, polyphagia, weight loss, ketonuria, prone to DKA
Type 2 Diabetes Mellitus
-
Accounts for 90-95% of all diabetes cases
-
Usually adults; increasingly seen in obese children/adolescents
-
Pathogenesis - two key defects:
- Insulin resistance: Peripheral tissues (especially skeletal muscle, adipose) show decreased responsiveness to insulin → GLUT-4 recruitment is impaired
- Relative β-cell dysfunction: β cells cannot compensate adequately for the increased insulin demand → progressive decline in insulin secretion
-
Associated with obesity (80% of cases), physical inactivity, family history
-
First-phase insulin response is lost early
-
No autoimmune markers; late pathology shows amyloid deposition in islets
-
Rarely develops DKA; may develop hyperosmolar hyperglycemic state (HHS)
Diagnostic Criteria for Diabetes Mellitus
| Test | Diagnostic Value |
|---|
| Fasting plasma glucose (FPG) | ≥ 126 mg/dL (≥ 7.0 mmol/L) |
| 2-hour plasma glucose (OGTT) | ≥ 200 mg/dL (≥ 11.1 mmol/L) |
| HbA1c | ≥ 6.5% |
| Random plasma glucose + symptoms | ≥ 200 mg/dL |
Pre-diabetes: FPG 100-125 mg/dL (Impaired Fasting Glucose) or OGTT 140-199 mg/dL (Impaired Glucose Tolerance)
Clinical Features of Diabetes
Classic symptoms (the "3 Ps"):
- Polyuria - osmotic diuresis due to glycosuria (glucose exceeds renal threshold ~180 mg/dL)
- Polydipsia - compensatory thirst due to water loss
- Polyphagia - cellular starvation despite hyperglycemia; hyperphagia to compensate
Other features: Weight loss, fatigue, blurred vision, recurrent infections, poor wound healing
Complications of Diabetes Mellitus
Acute Complications
| Complication | Type | Key Feature |
|---|
| Diabetic Ketoacidosis (DKA) | Type 1 DM | Absolute insulin deficiency → ↑ lipolysis → ketone body production (acetone, acetoacetate, β-hydroxybutyrate) → metabolic acidosis |
| Hyperosmolar Hyperglycemic State (HHS) | Type 2 DM | Severe hyperglycemia (>600 mg/dL), hyperosmolarity, no significant ketosis |
| Hypoglycemia | Overtreatment | Blood glucose <70 mg/dL; altered consciousness, sweating, tremors |
Chronic Complications
Microvascular (due to basement membrane thickening):
- Diabetic nephropathy - Kimmelstiel-Wilson nodules in glomeruli; leading cause of chronic kidney disease
- Diabetic retinopathy - non-proliferative → proliferative; leading cause of acquired blindness in adults
- Diabetic neuropathy - peripheral (glove-and-stocking sensory loss), autonomic (gastroparesis, impotence, postural hypotension)
Macrovascular (accelerated atherosclerosis):
- Coronary artery disease - leading cause of death in diabetics
- Peripheral vascular disease - diabetic foot, gangrene
- Cerebrovascular disease - stroke
Mechanism of Vascular Complications
- Advanced Glycation End-products (AGEs) - glucose non-enzymatically glycates proteins → AGEs cross-link collagen → basement membrane thickening
- Polyol pathway activation - glucose converted to sorbitol by aldose reductase → osmotic damage to cells (nerves, lens → cataract)
- Oxidative stress - excess reactive oxygen species damage endothelium
- PKC activation - protein kinase C promotes vascular permeability and proliferation
- Hexosamine pathway - impairs insulin signaling
Management Overview
| Type | Management |
|---|
| Type 1 DM | Insulin replacement (basal-bolus regimen); diet and exercise |
| Type 2 DM | Lifestyle modification → Metformin (first-line) → add-on agents (sulfonylureas, GLP-1 agonists, SGLT-2 inhibitors, DPP-4 inhibitors) → insulin when needed |
| Monitoring | Self-monitoring blood glucose (SMBG); HbA1c every 3 months; target HbA1c <7% |
SUMMARY DIAGRAM (for exam drawing)
MECHANISM OF INSULIN SECRETION (Glucose-Stimulated):
Blood Glucose ↑
↓
GLUT-2 transporter (β cell uptake)
↓
Glucokinase (glucose sensor)
↓
Glucose-6-phosphate → Glycolysis → ↑ ATP/ADP ratio
↓
K-ATP channel CLOSES (SUR1 + Kir6.2)
↓
Membrane DEPOLARIZATION
↓
Voltage-gated Ca²⁺ channels OPEN
↓
↑ Intracellular Ca²⁺
↓
Insulin granule EXOCYTOSIS
↓
Insulin + C-peptide released into portal vein
Sources: Goldman-Cecil Medicine (International Ed.) | Lippincott's Illustrated Biochemistry (8th ed.) | Costanzo Physiology (7th ed.) | Robbins & Kumar Basic Pathology | Katzung's Basic & Clinical Pharmacology (16th ed.)